ANEPHLA

Welcome to the Brand page for “ANEPHLA”, which is offered here for Pharmaceutical preparations, preparations for the treatment, control and prevention of human disorders and diseases resulting from hyperphosphatemia, hyperlipidemia, hypercholestrolemia, hyperparathyroidism, kidney dysfunction, and neurological, genetic, cardiovascular, gastrointestinal, urological, metabolic diabetic, allergy, obesity, and insulin resistance syndromes and conditions;.

Its status is currently believed to be active. Its class is unavailable. “ANEPHLA” is believed to be currently owned by “Mitsubishi Tanabe Pharma Corporation”.

Owner:
MITSUBISHI TANABE PHARMA CORPORATION
Owner Details
Description:
Pharmaceutical preparations, preparations for the treatment, control and prevention of human disorders and diseases resulting from hyperphosphatemia, hyperlipidemia, hypercholestrolemia, hyperparathyroidism, kidney dysfunction, and neurological, genetic, cardiovascular, gastrointestinal, urological, metabolic diabetic, allergy, obesity, and insulin resistance syndromes and conditions;
Categories: PHARMACEUTICAL PREPARATIONS